Earlier based on previous data and lack of IMS script data my estimate was $23 around Q2 but after reviewing the latest info,i have raised it to $26
Good luck to all
analysts expecting $84M and SNTS should land around $90M
Raised my Q3 target to $32
ALKS Fiscal Year 2013 Revenues Grew 48% Year-Over-Year to $575.5 Million with debt of $300 Million
Market cap $4.5Billion at $33
QCOR market cap $2.2B at $35 and annual sales of $500M
ARNA market cap of $2 Billion at $8 with $0 annual sales
SNTS market cap $1.3Billion with $350M annual sales and no debt
doesn't it look very cheap ?
MNKD makes no sale and market cap $2 Billion ?
I think you are pointing in the correct direction. Hold stock and let them do their work. LOL They know what they are doing in SNTS management.
Sentiment: Strong Buy
you want to say he is moving to the correct direction! I wonder if he is the same HATER ??? whose boss already profited with the temporary decline they created themselves to pick up the stop losses??? Or do I see red under each bed?
One very important point which we are missing is the worldwide rights for Uceris
If SNTS starts selling in North America, EMEA ( europe Middle East Asia ) , they will be making an easy $100M / quarter